Cumberland Pharmaceuticals (CPIX) Net Income (QoQ) (2010 - 2026)
Cumberland Pharmaceuticals (CPIX) Net Income (QoQ) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.97 Bn | 36.23 Bn | 1.97 Bn |
| 2 | Zoetis | 33.59 Bn | 31.65 Bn | 1.62 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn |
| 4 | Neurocrine Biosciences | 16.10 Bn | 14.78 Bn | 800.70 Mn |
| 5 | Aurora Cannabis | 15.56 Bn | 15.47 Bn | 21.72 Mn |
| 6 | Elanco Animal Health | 12.04 Bn | 11.61 Bn | 785.00 Mn |
| 7 | Alkermes | 7.36 Bn | 6.84 Bn | -116.06 Mn |
| 8 | Lantheus Holdings | 6.74 Bn | 6.24 Bn | 230.92 Mn |
| 9 | Liquidia | 6.27 Bn | 6.04 Bn | 121.79 Mn |
| 10 | Cumberland Pharmaceuticals | 84.67 Mn | 73.33 Mn | 7.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -121.95% |
| Dec 31, 2025 | 27.39% |
| Sep 30, 2025 | -165.10% |
| Jun 30, 2025 | -158.90% |
| Mar 31, 2025 | 165.64% |
| Dec 31, 2024 | -23.73% |
| Sep 30, 2024 | -39.39% |
| Jun 30, 2024 | 42.04% |
| Mar 31, 2024 | 69.81% |
| Dec 31, 2023 | -492.73% |
| Sep 30, 2023 | -223.32% |
| Jun 30, 2023 | 400.42% |
| Dec 31, 2021 | 1.31% |
| Sep 30, 2021 | -0.40% |
| Jun 30, 2021 | 0.69% |
| Mar 31, 2021 | -43.19% |
| Dec 31, 2020 | 12.10% |
| Sep 30, 2020 | 5.32% |
| Jun 30, 2020 | -9.73% |
| Mar 31, 2020 | -65.86% |